Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ORGANIZATION
ORGANIZATION
- Tohoku Pharmaceutical Univ. to Acquire Tohoku Kosei Nenkin Hospital, Aiming to Turn It into Model Hospital for Pharmaceutical Education
December 14, 2012
- Panelists at IGPA Conference Express Concern that FTA Could Strengthen Intellectual Property Rights
December 10, 2012
- GIST Patients Group Submits Petition Calling for Early Filing for Regorafenib for GIST
December 10, 2012
- Kyoto Declaration Calls for Strict Quality Control of Generics: IGPA Annual Conference
December 10, 2012
- Biosimilars Popular Topic at IGPA Annual Conference
December 10, 2012
- Ways to Deal with Biosimilars Will Be Common Challenge Among Generics Companies: JGA President Sawai
December 6, 2012
- Drug Costs Should Be Basically Borne by Patients under Compassionate Use System: JPMA’s Kuwahara
December 5, 2012
- 80 Medical Institutions Submit Comprehensive Agreements on Info Disclosure in Response to JPMA Transparency GLs
December 4, 2012
- Top Officials of FPMAJ, JGA Disagree on Progress in Generic Drug Use at CSIMC Expert Subcommittee Meeting
November 30, 2012
- Pharmaceutical Makers to Reap Equal Benefits from Premium for New Drug Development in Long Run: FPMAJ Chief Naito
November 29, 2012
- IGPA Annual Conference to Adopt Kyoto Declaration including Int’l Harmonization on Generic Evaluation Criteria
November 28, 2012
- JMA to Call on PAFSC Committee to Review Once Again Switch-OTC of Epadel
November 27, 2012
- 27 JPMA Member Companies’ 1st Half Sales Up 2.1%
November 26, 2012
- JPMA to Compile “Code of Practice,” Eyeing Implementation from April
November 16, 2012
- JPMA Reprimands Mitsubishi Tanabe for GMP Violation by Benesis
November 16, 2012
- JSPE to Introduce Pharmacovigilance Specialist Certification System to Support RMPs
November 14, 2012
- Industry, Academia Launch Project to Raise Public Awareness of COPD
November 1, 2012
- Officials from MOPH of Thailand Receive Quality Control Training: JPMA’s Int’l Cooperation Activities
October 26, 2012
- 1st Graduates Under 6-Year Pharmacy Education System Push Up Percentage of Qualified Pharmacists among Applicants for This Year’s MR Exam: MREAC
October 24, 2012
- Nearly 1,200 Municipalities Cover Full Cost of HPV Vaccinations: Expert Organization Survey
October 23, 2012
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s FY2026 drug pricing reform is set to usher in a new phase for the generics market, effectively bringing an…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…